These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 18804269)

  • 21. [Replacement therapy with subcutaneous immunoglobulin in primary immunodeficiency in children].
    Pac M
    Pol Merkur Lekarski; 2011 Jun; 30(180):413-6. PubMed ID: 21751550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcutaneous immunoglobulin: rapid push vs. infusion pump in pediatrics.
    Shapiro RS
    Pediatr Allergy Immunol; 2013 Feb; 24(1):49-53. PubMed ID: 23331529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The patient: Emerging clinical applications of intravenous immunoglobulin.
    Harvey RD
    Pharmacotherapy; 2005 Nov; 25(11 Pt 2):85S-93S. PubMed ID: 16229679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab and intravenous immunoglobulins for relapsing postinfectious opsoclonus-myoclonus syndrome.
    Leen WG; Weemaes CM; Verbeek MM; Willemsen MA; Rotteveel JJ
    Pediatr Neurol; 2008 Sep; 39(3):213-7. PubMed ID: 18725071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommended indications for the administration of polyclonal immunoglobulin preparations.
    Delforge M; Farber CM; Spath P; Kaveri S; Witte T; Misbah SA; Hübner R; Haerynck F; Latinne D; Muylle L; Toungouz M; Deneys V;
    Acta Clin Belg; 2011; 66(5):346-60. PubMed ID: 22145269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacoeconomic advantages of subcutaneous versus intravenous immunoglobulin treatment in a Canadian pediatric center.
    Ducruet T; Levasseur MC; Des Roches A; Kafal A; Dicaire R; Haddad E
    J Allergy Clin Immunol; 2013 Feb; 131(2):585-7.e1-3. PubMed ID: 23040368
    [No Abstract]   [Full Text] [Related]  

  • 27. 7th International Immunoglobulin Conference: Poster presentations.
    Warnatz K; Ballow M; Stangel M; Bril V
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):162. PubMed ID: 25546805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous gammaglobulin treatment in HIV-1 infection.
    Deener A; Mehra A; Bernstein L; Shliozberg J; Rubinstein A
    Immunol Allergy Clin North Am; 2008 Nov; 28(4):851-9, x. PubMed ID: 18940578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous immunoglobulin therapy.
    Stein LD; Roifman CM
    Bull Rheum Dis; 1995 Jun; 44(4):3-5. PubMed ID: 7787963
    [No Abstract]   [Full Text] [Related]  

  • 30. Subcutaneous administration of IgG.
    Berger M
    Immunol Allergy Clin North Am; 2008 Nov; 28(4):779-802, viii. PubMed ID: 18940574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel aspects of hypogammaglobulinemic states: subcutaneous immunoglobulin treatment.
    Grunebaum E; Levy Y; Shoenfeld Y
    Isr Med Assoc J; 2002 Apr; 4(4):288-9. PubMed ID: 12001706
    [No Abstract]   [Full Text] [Related]  

  • 32. A case of lichenoid drug eruption associated with subcutaneous immunoglobulin therapy.
    Beccastrini E; Emmi G; Caproni M; Antiga E; Francalanci S; Lorenzoni A; Emmi L
    Clin Immunol; 2011 May; 139(2):228-30. PubMed ID: 21402497
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravenous immunoglobulin.
    Hochwald C; Farrington E
    Pediatr Nurs; 1996; 22(4):344-7. PubMed ID: 8852117
    [No Abstract]   [Full Text] [Related]  

  • 34. High-dose intravenous immunoglobulin monotherapy for drug-induced hypersensitivity syndrome.
    Kito Y; Ito T; Tokura Y; Hashizume H
    Acta Derm Venereol; 2012 Jan; 92(1):100-1. PubMed ID: 21681351
    [No Abstract]   [Full Text] [Related]  

  • 35. Immune supplementation and immune modulation with intravenous immunoglobulin.
    Mazer BD; Al-Tamemi S; Yu JW; Hamid Q
    J Allergy Clin Immunol; 2005 Oct; 116(4):941-4. PubMed ID: 16210080
    [No Abstract]   [Full Text] [Related]  

  • 36. Subcutaneous immunoglobulin infusion to treat infants and toddlers with antibody deficiencies.
    Meth MJ; Rosenthal DW; Bonagura VR
    Ann Allergy Asthma Immunol; 2010 Aug; 105(2):187-8. PubMed ID: 20674834
    [No Abstract]   [Full Text] [Related]  

  • 37. Intravenous immunoglobulin treatment of immunodeficiency. Preface.
    Roifman CM
    Immunol Allergy Clin North Am; 2008 Nov; 28(4):xv-xvi. PubMed ID: 18940569
    [No Abstract]   [Full Text] [Related]  

  • 38. Potential Anti-Tumor Activity of Intravenous and Subcutaneous Immunoglobulin.
    Danieli MG; Gelardi C; Pedini V; Gabrielli A
    Isr Med Assoc J; 2018 Dec; 20(12):782-783. PubMed ID: 30550011
    [No Abstract]   [Full Text] [Related]  

  • 39. New uses of intravenous immune globulin therapy.
    Wilson NW; Bastian JF
    West J Med; 1991 Apr; 154(4):461. PubMed ID: 1877192
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravenous immunoglobulin therapy: indications, potential side effects, and treatment guidelines.
    Suez D
    J Intraven Nurs; 1995; 18(4):178-90. PubMed ID: 7629638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.